ADIPOQ and morbid obesity: The aim of this study was to evaluate the potential role of adipokines such as chemerin and adiponectin and PVAT morphological characteristics as biomarkers associated with arterial stiffness in patients with morbid obesity, given its role of independent cardiovascular risk factor.